A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Two Fixed-Dose Leucine, Sildenafil and Metformin Combinations (NS-0200) Versus Placebo on Blood Pressure in Individuals With Hypertension
Latest Information Update: 19 Jun 2026
At a glance
- Drugs Leucine/metformin/sildenafil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms NS-HTN-01
- Sponsors NuSirt Biopharma
Most Recent Events
- 17 Jun 2026 Status changed from planning to not yet recruiting.
- 09 Jun 2015 New trial record
- 06 Jun 2015 Initiation of this trial is planned later in 2015, according to a NuSirt Biopharma media release.